Pfizer PBC 125 (Ibrance 125 mg)
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Purple, Elliptical / Oval and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..
Ibrance is used in the treatment of breast cancer, metastatic; breast cancer, male; liposarcoma; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer PBC 125
Related Images for "Pfizer PBC 125"
More about Ibrance (palbociclib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 61 Reviews
- Drug class: CDK 4/6 inhibitors
- FDA Alerts (1)
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.